Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management

Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management

Abstract Background There is conflicting evidence of benefit versus harm for warfarin anticoagulation in hemodialysis patients with atrial fibrillation. This equipoise may be explained by suboptimal Time in Therapeutic Range (TTR), which correlates well with thromboembolic and bleeding complications...

Full description

Bibliographic Details
Main Authors: Hamad Bahbahani, Ahmed AlTurki, Ahmed Dawas, Mark L. Lipman
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Nephrology
Subjects:
Hemodialysis
Atrial fibrillation
Warfarin
Time in therapeutic range
International normalized ratio (INR)
Online Access:http://link.springer.com/article/10.1186/s12882-017-0809-x

Internet

http://link.springer.com/article/10.1186/s12882-017-0809-x

Similar Items